Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
ACS Appl Mater Interfaces ; 15(46): 53568-53583, 2023 Nov 22.
Article in English | MEDLINE | ID: mdl-37943692

ABSTRACT

Tetracyanonickelate (TCN)-based metal-organic frameworks (MOFs) show great potential in electrochemical applications such as supercapacitors due to their layered morphology and tunable structure. This study reports on improved electrochemical performance of exfoliated manganese tetracyanonickelate (Mn-TCN) nanosheets produced by the heat-assisted liquid-phase exfoliation (LPE) technique. The structural change was confirmed by the Raman frequency shift of the C≡N band from 2177 to 2182 cm-1 and increased band gap from 3.15 to 4.33 eV in the exfoliated phase. Statistical distribution obtained from atomic force microscopy (AFM) shows that 50% of the nanosheets are single-to-four-layered and have an average lateral size of ∼240 nm2 and thickness of ∼1.2-4.8 nm. High-resolution transmission electron microscopy (HRTEM) and selected area electron diffraction (SAED) patterns suggest that the material maintains its crystallinity after exfoliation. It exhibits an almost 6-fold improvement in specific capacitance (from 13.0 to 72.5 F g-1) measured at a scan rate of 5 mV s-1 in 1 M KOH solution. Galvanostatic charge-discharge (GCD) measurement shows a capacity enhancement from ∼18 F g-1 in the bulk phase to ∼45 F g-1 in the exfoliated phase at a current density of 1 A g-1. Bulk crystals exhibit an increasing trend of capacitance retention by ∼125% over 1000 charge-discharge cycles attributed to electrochemical exfoliation. Electrochemical impedance spectroscopy (EIS) demonstrates a 5-fold reduction in the total equivalent series resistance (ESR) from 4864 Ω (bulk) to 1089 Ω (exfoliated). The enhanced storage capacity in the exfoliated phase results from the combined effect of the electrochemical double-layer charge storage mechanism at the nanosheet-electrolyte interface and the Faradic process characteristic of the pseudocapacitive charge storage behavior.

2.
ACS Appl Mater Interfaces ; 15(39): 46269-46279, 2023 Oct 04.
Article in English | MEDLINE | ID: mdl-37748041

ABSTRACT

A newly discovered quenched form of carbon, widely known as Q-carbon, thin films are synthesized by the direct conversion of the amorphous carbon layer using the nanosecond pulsed laser annealing technique, and its corrosion-resistant properties, that is, potentiodynamic polarization (PDP) and electrochemical impedance spectroscopy technique, are investigated. The unique microstructure and the existence of defects (sp2 content) in sp3-rich Q-carbon are highly desirable for efficient corrosion-resistant performance. The sp3 percentage of the as-grown Q-carbon is measured to be ∼80.5% from the D and G peaks of the Raman and C-1S X-ray photoelectron spectrum. The anti-corrosion properties with inhibition durability of Q-carbon thin films are systematically investigated in various concentrations of Na2SO4 solutions, and the corrosion potential, corrosion current, and corrosion rate of Q-carbon are determined to be -253 V, 30.1 × 10-5 A/cm2, and 0.00528, respectively, for 1 M Na2SO4 solution. Both series and contact resistance decrease from 5498.6 and 821.1 Ω to 698.8 and 124.3 Ω with an increase of Na2SO4 concentration from 0.1 to 1 M, respectively. The small shift of PDP curves toward more negative potential, the shrinkage of the radius of semicircular arcs in the Nyquist plot (Z″ vs Z'), and negligible loss in corrosion resistance (∼78%) are observed for Q-carbon thin film at the immersion time up to 48 h. The unique sp2-sp3 ratio, shorter bond length, compact atomic arrangement, and minimum porosity, along with the high adhesion strength, due to the ultrafast solid-liquid-solid growth route, of Q-carbon thin film on the substrate signify it as a better alternative compared to the existing corrosion-resistant materials.

3.
ACS Omega ; 8(10): 9307-9318, 2023 Mar 14.
Article in English | MEDLINE | ID: mdl-36936320

ABSTRACT

In this paper, we report the excellent field emission properties of Q-carbon and analyze its field emission characteristics through structural, morphological, and electronic property correlations, supported by density functional theory (DFT) simulation studies. The Q-carbon field emitters show impressive and stable field emission properties, such as a low turn-on electric field of ∼2.38 V/µm, a high emission current density of ∼33 µA/cm2, and a critical field of ∼2.44 V/µm for the transition from a linear region to the saturation region in the F-N plot. The outstanding field emission properties of Q-carbon are attributed to (i) a unique sp2/sp3 mixture in Q-carbon, (ii) sp2-bonded highly conductive amorphous carbon-rich channels inside the Q-carbon cluster, (iii) a large local field enhancement due to the local geometry and microstructure of Q-carbon, and (iv) the presence of sp2-bonded amorphous carbon regions in the composite film. The temperature-dependent field emission properties, such as extreme sensitivity and an enhancement in the emission current density with temperature, can be explained by the local density of states near the Fermi level and the excellent thermal stability of the Q-carbon field emitters. From DFT simulation studies, the computed work function and the field-enhancement factor were determined to be 3.62 eV and ∼2300, respectively, which explains the excellent field emission characteristics of Q-carbon. The obtained field emission properties, in most cases, were superior to those from other carbon/diamond-based field emitters, which will open new frontiers in field emission-based electronic applications.

4.
ACS Appl Mater Interfaces ; 15(6): 8305-8318, 2023 Feb 15.
Article in English | MEDLINE | ID: mdl-36735879

ABSTRACT

Novel phase Q-carbon thin films exhibit some intriguing features and have been explored for various potential applications. Herein, we report the growth of different Q-carbon structures (i.e., filaments, clusters, and microdots) by varying the laser energy density from 0.5 to 1.0 J/cm2 during pulsed laser annealing of amorphous diamond-like carbon films with different sp3-sp2 carbon compositions. These unique nano- and microstructures of Q-carbon demonstrate exceptionally stable electrochemical performance by cyclic voltammetry, galvanostatic charging-discharging, and electrochemical impedance spectroscopy for energy applications. The temperature-dependent magnetic studies (magnetization vs magnetic field and temperature) reveal the ferromagnetic nature of the Q-carbon microdots. The saturation magnetization and coercive field values decrease from 132 to 14 emu/cc and 155 to 92 Oe by increasing the temperature from 2 to 300 K, respectively. The electrochemical performances of Q-carbon filament, cluster, and microdot thin-film supercapacitors were investigated by two-electrode configurations, and the highest areal specific capacitance of ∼156 mF/cm2 was observed at a current density of 0.15 mA/cm2 in the Q-carbon microdot thin film. The Q-carbon microdot electrodes demonstrate an exceptional capacitance retention performance of ∼97.2% and Coulombic efficiency of ∼96.5% after 3000 cycles due to their expectational reversibility in the charging-discharging process. The kinetic feature of the ion diffusion associated with the charge storage property is also investigated, and small changes in equivalent series resistance of ∼9.5% and contact resistance of ∼9.1% confirm outstanding stability with active charge kinetics during the stability test. A high areal power density of ∼5.84 W/cm2 was obtained at an areal energy density of ∼0.058 W h/cm2 for the Q-carbon microdot structure. The theoretical quantum capacitance was obtained at ∼400 mF/cm2 by density functional theory calculation, which gives an idea about the overall capacitance value. The obtained areal specific capacitance, power density, and impressive long-term cyclic stability of Q-carbon thin-film microdot electrodes endorse substantial promise in high-performance supercapacitor applications.

5.
Sci Rep ; 12(1): 14681, 2022 08 29.
Article in English | MEDLINE | ID: mdl-36038600

ABSTRACT

Development of effective vaccines have been immensely welcomed by the world to prevent the transmission of SARS-CoV-2. However, the duration and clinical implications of antibody-mediated natural immunity in SARS-CoV-2 have not been adequately elucidated alongside some other immune system transforming factors. In a cohort study, we measured NAb titer following the 2nd immunization dosage of the CoviShield (AZD1222) vaccine. The enzyme-linked immunoassay was used to look for SARS-CoV-2-specific NAb. We measured NAb at 30 days after the 2nd dosage of immunization and > 96% titer was detected in 42.9% of subjects, but only 5.1% of subjects retained the same level after 180 days. The median NAb titer dropped significantly, from 92% at 30 days to 58% at 180 days (p < 0.001). Besides, there were significant differences observed in NAb titer after 180 days by age, sex, COVID-19 infection, tobacco use, and asthma patients. However, SARS-CoV-2 infection along with two dosages of immunization upheld NAb titer (p < 0.001) even at the end of the study period.


Subject(s)
COVID-19 , SARS-CoV-2 , Antibodies, Neutralizing , Antibodies, Viral , COVID-19/prevention & control , ChAdOx1 nCoV-19 , Cohort Studies , Humans
6.
Nanomaterials (Basel) ; 12(5)2022 Mar 03.
Article in English | MEDLINE | ID: mdl-35269341

ABSTRACT

Diamond is one of the fascinating films appropriate for optoelectronic applications due to its wide bandgap (5.45 eV), high thermal conductivity (3320 W m-1·K-1), and strong chemical stability. In this report, we synthesized a type of diamond film called nanocrystalline diamond (NCD) by employing a physical vapor deposition method. The synthesis process was performed in different ratios of nitrogen and hydrogen mixed gas atmospheres to form nitrogen-doped (n-type) NCD films. A high-resolution scanning electron microscope confirmed the nature of the deposited films to contain diamond nanograins embedded into the amorphous carbon matrix. Sensitive spectroscopic investigations, including X-ray photoemission (XPS) and near-edge X-ray absorption fine structure (NEXAFS), were performed using a synchrotron beam. XPS spectra indicated that the nitrogen content in the film increased with the inflow ratio of nitrogen and hydrogen gas (IN/H). NEXAFS spectra revealed that the σ*C-C peak weakened, accompanied by a π*C=N peak strengthened with nitrogen doping. This structural modification after nitrogen doping was found to generate unpaired electrons with the formation of C-N and C=N bonding in grain boundaries (GBs). The measured electrical conductivity increased with nitrogen content, which confirms the suggestion of structural investigations that nitrogen-doping generated free electrons at the GBs of the NCD films.

7.
BMC Complement Med Ther ; 21(1): 225, 2021 Sep 04.
Article in English | MEDLINE | ID: mdl-34481509

ABSTRACT

BACKGROUND: Cisplatin is an outstanding anticancer drug, but its use has been decreased remarkably due to sever nephrotoxicity. R. vesicarius L. is a leafy vegetable that is evident with anti-angeogenic, anti-inflammatory, anti-proliferative, hepatoprotective, and nephroprotective potential. Therefore, this study was designed to inspect its methanol extract (RVE) for possible nephroprotective effect. METHODS: Primarily, in vitro antioxidant activity of RVE was confirmed based on 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging aptitude. Thereafter, Swiss Albino male mice were treated with cisplatin (2.5 mg/kg) for 5 successive days to induce nephrotoxicity. Recovery from nephrotoxicity was scrutinized by treating the animals with RVE (25, 50, and 100 mg/kg) intraperitoneally (i.p.) for the next 5 consecutive days. After completion of treatment, mice were sacrificed and kidneys were collected. Part of it was homogenized in sodium phosphate buffer for evaluating malondialdehyde (MDA) level, another part was used to evaluate gene (NQO1, p53, and Bcl-2) expression. Moreover, the hydrogen peroxide (H2O2) neutralizing capacity of RVE was evaluated in HK-2 cells in vitro. Finally, bioactive phytochemicals in RVE were determined using gas chromatography-mass spectrometry (GC-MS). RESULTS: RVE showed in vitro antioxidant activity in a dose-dependent fashion with 37.39 ± 1.89 µg/mL IC50 value. Treatment with RVE remarkably (p < 0.05) decreased MDA content in kidney tissue. Besides, the expression of NQO, p53, and Bcl-2 genes was significantly (p < 0.05) mitigated in a dose-dependent manner due to the administration of RVE. RVE significantly (p < 0.05) reversed the H2O2 level in HK-2 cells to almost normal. From GC-MS, ten compounds including three known antioxidants "4H-Pyran-4-one, 2, 3-dihydro-3,5-dihydroxy-6-methyl-", "Hexadecanoic acid", and "Squalene" were detected. The extract was rich with an alkaloid "13-Docosenamide". CONCLUSION: Overall, RVE possesses a protective effect against cisplatin-induced kidney damage.


Subject(s)
Antioxidants/pharmacology , Kidney/drug effects , Methanol/pharmacokinetics , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Animals , Cisplatin/pharmacology , Hydrogen Peroxide/pharmacology , Mice
8.
Nanomaterials (Basel) ; 10(3)2020 Mar 20.
Article in English | MEDLINE | ID: mdl-32245105

ABSTRACT

Improvement of magnetic, electronic, optical, and catalytic properties in cutting-edge technologies including drug delivery, energy storage, magnetic transistor, and spintronics requires novel nanomaterials. This article discusses the unique, clean, and homogeneous physiochemical synthesis of BaTiO3/iron oxide core-shell nanoparticles with interfaces between ferroelectric and ferromagnetic materials. High-resolution transmission electron microscopy displayed the distinguished disparity between the core and shell of the synthesized nanoparticles. Elemental mapping and line scan confirmed the formation of the core-shell structure. Energy-dispersive X-ray spectroscopy and X-ray photoelectron spectroscopy detected the surface iron oxide phase as maghemite. Rietveld analysis of the X-ray diffraction data labeled the crystallinity and phase purity. This study provides a promising platform for the desirable property development of the futuristic multifunctional nanodevices.

9.
Plant Physiol Biochem ; 150: 254-262, 2020 May.
Article in English | MEDLINE | ID: mdl-32171164

ABSTRACT

Iron (Fe)-deficiency causes chlorosis and growth inhibition in sunflower, an important commercial crop. This study examines whether and how arbuscular mycorrhizal fungi (AMF) ameliorate Fe-deficiency symptoms in Fe-deficiency sensitive sunflower plants. AMF supplementation showed a significant improvement in plant biomass, chlorophyll score, Fv/Fm (quantum efficiency of photosystem II), and Pi_ABS (photosynthesis performance index), suggesting its beneficial effect under Fe deficiency. This AM-driven amelioration of Fe deficiency was further supported by the improvement of biochemical stress indicators, such as cell death, electrolyte leakage, superoxide anion, and hydrogen peroxide. In this study, the AMF supplementations resulted in significant improvement in Fe as well as Zn concentrations in root and shoot of sunflower under Fe deficiency. One of the primary Strategy-I responses, ferric reductase activity along with the expression of its respective gene (HaFRO1), significantly increased in roots due to AMF ensuring Fe availability in the rhizosphere under Fe deficiency. Our qPCR analysis also showed a significant upregulation of HaIRT1, HaNramp1, and HaZIP1 in roots of sunflower in the presence of AMF, suggesting that Fe and Zn transporters are concurrently involved with AMF-mediated alleviation of Fe deficiency. Further, AMF accelerates the activities of CAT and SOD, predominantly in roots to protect sunflower plants from Fe-deficiency reactive oxygen species (ROS). This study unveils the mechanistic basis of AMF to limit Fe deficiency retardation in sunflower.


Subject(s)
Helianthus , Mycorrhizae , Electrolytes , Gene Expression Regulation, Plant/drug effects , Helianthus/metabolism , Helianthus/microbiology , Iron Deficiencies , Mycorrhizae/physiology , Oxidoreductases/metabolism
10.
Toxicol Res ; 35(3): 271-277, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31341556

ABSTRACT

Citrus macroptera (Rutaceae) has long been used in folk medicine in Bangladesh. Considering the folkloric context, this study was aimed to scrutinize anti-proliferative activity of C. macroptera fruit pulp juice (CMFPJ) against Ehrlich's ascites carcinoma (EAC). The anti-proliferative capacity of CMFPJ was investigated and confirmed primarily using MTT assay. In vivo anti-proliferative aptitude of CMFPJ was investigated with 25, 50, and 100 mg/kg/day intraperitoneal (i.p.) treatment. Anti-proliferative efficacy of CMFPJ was assessed based on EAC growth inhibition. CMFPJ inhibited EAC growth in vitro in a dose-dependent manner. And the percentages of in vivo EAC growth inhibition were 19.53, 49.2, and 68.9% at 25, 50, and 100 mg/kg CMFPJ respectively. CMFPJ significantly induced expression of apoptosis regulatory genes caspase-8, caspase-9, cytochrome-c, and caspase-3. This considerable anti-cancer activity was perhaps due to combinatorial effect of lectin, polyphenols, and flavonoids present in CMFPJ.

11.
IEEE Trans Nanobioscience ; 18(3): 490-497, 2019 07.
Article in English | MEDLINE | ID: mdl-31144642

ABSTRACT

In this study, we have investigated the structural and optical properties of nanoconjugates (NJs) consisting of phase pure zinc oxide (ZnO) nanoparticles (NPs) with glucose biomolecules. All NJs were fabricated using a standard biochemical synthesis process. Structural, optical, vibrational, and biochemical interface properties of nano-bio composites are probed by different complementary characterization techniques. The XRD patterns of the NPs and NJs illustrate a highly phase pure ZnO structure. A visible green emission in the photoluminescence spectrum, mainly associated with the oxygen vacancies on the surface of ZnO nanostructure, is significantly reduced by the incorporation of glucose biomolecules. The strong binding interaction of glucose biomolecule on the surface of ZnO NPs results in the reduction in green-yellow-orange emission intensities. The interaction of glucose molecules modifies oxygen vacancies by capturing free electrons from the ZnO surface region. Significant changes in the peak intensity and relative peak position of some of the glucose and ZnO NPs in Raman spectra refer to the direct binding between these two nano- and bio-components. In the X-ray photoelectron spectroscopy, the binding energy of O 1s core level in NJs increases from 531 eV (O 1s core level position for ZnO) and the increment is more with higher initial glucose concentration in the solution during synthesis. This study serves as a promising platform for the development of new kinds of NJs and investigation of their interfacial properties which can take the frontier forward for integration and multifunctionality.


Subject(s)
Glucose/chemistry , Metal Nanoparticles/chemistry , Nanoconjugates/chemistry , Nanotechnology/methods , Zinc Oxide/chemistry , Glucose/metabolism , Luminescent Measurements , Spectrum Analysis , Zinc Oxide/metabolism
12.
J Phys Condens Matter ; 31(22): 225801, 2019 Jun 05.
Article in English | MEDLINE | ID: mdl-30818302

ABSTRACT

We report an experimental study for the structural and magnetic properties of highly pure LaFe0.5Mn0.5O3 perovskite phase. The impurity free LaFe0.5Mn0.5O3 has been prepared by sol-gel technique at 500 °C and annealed at different temperatures up to 1000 °C. Previous works on LaFe0.5Mn0.5O3 revealed presence of secondary phases along with contradicting magnetic properties. Such as, Bhame et al (2005 Phys. Rev. B 72 054426-7) reported the superparamagnetic or spin-glass like behavior for 200 °C treated sample that persisted even at 700 °C sample. However, Wei et al (2012 Mater. Chem. Phys. 136 755-61) claimed room temperature ferromagnetism in all the samples annealed in the range of 600 °C-700 °C where the saturation magnetization decreases with the increase in temperature. These contradicting results lead us to revisit the effect of annealing temperature on the magnetic properties of LaFe0.5Mn0.5O3. We noticed a gradual increase in magnetization with increase in annealing temperatures without any signature of long range spin ordering for pure single phase samples. The increased magnetic moment with annealing temperatures has been attributed to the suppression of surface contribution of disordered spin. The low temperature magnetic behaviors can be explained by the interacting cluster glass behavior for the pristine as well as for 1000 °C annealed samples.

13.
Dalton Trans ; 47(14): 5011-5018, 2018 Apr 03.
Article in English | MEDLINE | ID: mdl-29561042

ABSTRACT

Here, we report the luminescence based sensing of trace amounts of nitroaromatic explosive organic compounds. The luminescence emission of nanosized spinel oxide ZnCr2O4 with high chemical and thermal stabilities has been used as a potential probe to detect such organic explosives. Low temperature solution combustion synthesized ZnCr2O4 oxide with an average particle size of ∼9 nm exhibits strong luminescence emission at 410 nm upon excitation at 260 nm in an aqueous suspension. The presence of nitroaromatics in ZnCr2O4 suspension dramatically suppresses the luminescence emission providing an opportunity to detect it quantitatively. The detection limit for 2,4,6-trinitrophenol (TNP) is as low as 23 ppb. A number of organic compounds have been investigated for a comprehensive understanding. The astonishing sensitivity of ZnCr2O4 nanoparticles towards nitro explosives is appealing for sensing application. A plausible explanation of such luminescence quenching has been ascribed to a two-fold mechanism. The underling mechanism is further substantiated by a similar study on ZnO nanoparticles.

14.
Nanomaterials (Basel) ; 8(2)2018 Jan 25.
Article in English | MEDLINE | ID: mdl-29370084

ABSTRACT

In this study, we synthesize high quality vertically aligned ZnO (VAZO) nanorods on silicon, sapphire, and indium tin oxide (ITO) substrates by using pulsed laser deposition (PLD) technique at high growth pressure (0.3 Torr). Systematic changes in structural and optical properties of VAZO nanorods are studied by varying the substrate temperature (500-600 °C) and number of pulsed laser shots during the deposition. ZnO nanoparticles deposited at high pressure act as nucleation sites, eliminating requirement of catalyst to fabricate VAZO nanorods. Two sharp ZnO peaks with high intensity correspond to the (0002) and (0004) planes in X-ray diffraction pattern confirm the growth of ZnO nanorods, oriented along the c-axis. Scanning Electron Microscopy (SEM) images indicate a regular arrangement of vertically aligned hexagonal closed pack nano-structures of ZnO. The vertical alignment of ZnO nanorods is also supported by the presence of E2 (high) and A1 (LO) modes in Raman spectra. We can tune the diameter of VAZO nanorods by changing growth temperature and annealing environments. Photoluminescence spectroscopy illustrates reduction in defect level peak intensities with increase in diameter of VAZO nanorods. This study signifies that high pressure PLD technique can be used more efficiently for controlled and efficient growth of VAZO nanorods on different substrates.

15.
Funct Plant Biol ; 43(11): 1070-1081, 2016 Nov.
Article in English | MEDLINE | ID: mdl-32480527

ABSTRACT

Excess iron (Fe) is phytotoxic and causes reduced growth and productivity in rice. In this study we elucidated the mechanisms conferring differential tolerance to Fe-toxicity in rice seedlings. Excess Fe caused retardation in roots of both Pokkali and BRRI 51, but it caused no significant changes on growth parameters, Fe accumulation and OsIRT1 expression in shoots of Pokkali only compared with control plants. These results suggest that the Pokkali genotype does have mechanisms in shoots to withstand Fe toxicity. Pokkali maintained membrane stability and total soluble protein in shoots due to Fe toxicity, further confirming its ability to tolerate excess Fe. Furthermore, a significant decrease of Fe-chelate reductase activity and OsFRO1 expression in shoots of Pokkali suggests that limiting Fe accumulation is possibly regulated by Fe-reductase activity. Our extensive expression analysis on the expression pattern of three chelators (OsDMAS1, OsYSL15, OsYSL2 and OsFRDL1) showed no significant changes in expression in shoots of Pokkali due to Fe toxicity, whereas these genes were significantly upregulated under Fe-toxicity in sensitive BRRI 51. These results imply that regulation of Fe chelation in shoots of Pokkali contributes to its tolerance to Fe toxicity. Finally, increased catalase (CAT), peroxidase (POD), glutathione reductase (GR) and superoxide dismutase (SOD), along with elevated ascorbic acid, glutathione, cysteine, methionine and proline in shoots of Pokkali caused by Fe toxicity suggests that strong antioxidant defence protects rice plants from oxidative injury under Fe toxicity. Taking these results together, we propose that genetic variation in Fe-toxicity tolerance in rice is shoot based, and is mainly associated with the regulation of translocation and chelation of Fe together with elevated antioxidant metabolites in shoots.

16.
Phytomedicine ; 20(14): 1288-96, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-23867650

ABSTRACT

Pea (Pisum sativum L.) lectin is known to have interesting pharmacological activities and of great interest on biomedical research. In the current research pea lectin was purified followed by ion exchange chromatography on DEAE column and affinity chromatography on glucose-sepharose column. The lectin shown 11.7-84% inhibitory effect against Ehrlich ascites carcinoma (EAC) cells at the concentration range of 8-120 µg/ml in RPMI 1640 medium as determined by MTT assay. Pea lectin was also shown 63% and 44% growth inhibition against EAC cells in vivo in mice when administered 2.8 mg/kg/day and 1.4 mg/kg/day (i.p.) respectively for five consequent days. When Pea lectin injected into the EAC bearing mice for 10 days its significantly increased the hemoglobin and RBC with the decreased of WBC levels toward the normal. Apoptotic cell morphological change of the treated EAC cells of mice was determined by fluorescence and optical microscope. Interestingly, cell growth inhibition of the lectin was significantly reduced in the presence of caspase inhibitors. Treatment with the lectin caused the cell cycle arrest at G2/M phase of EAC cells which was determined by flow cytometry. The expression of apoptosis-related genes, Bcl-2, Bcl-X and Bax was evaluated by reverse transcriptase polymerase chain reaction (RT-PCR). Intensive increase of Bax gene expression and totally despaired of Bcl-2 and Bcl-X gene expression were observed in the cells treated with Pea lectin for five consecutive days.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Apoptosis/drug effects , Carcinoma, Ehrlich Tumor/drug therapy , Cell Cycle Checkpoints/drug effects , Phytotherapy , Pisum sativum/chemistry , Plant Lectins/therapeutic use , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Carcinoma, Ehrlich Tumor/blood , Carcinoma, Ehrlich Tumor/metabolism , Caspase Inhibitors/pharmacology , Erythrocyte Count , Gene Expression/drug effects , Hemoglobins/metabolism , Leukocyte Count , Mice , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Lectins/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , bcl-2-Associated X Protein/metabolism
17.
J Clin Oncol ; 30(35): 4323-9, 2012 Dec 10.
Article in English | MEDLINE | ID: mdl-23109697

ABSTRACT

PURPOSE: The association between initial molecular response and longer-term outcomes with nilotinib was examined. PATIENTS AND METHODS: Patients with imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase from the phase II nilotinib registration study with available postbaseline BCR-ABL1 transcript assessments were included (N = 237). RESULTS: BCR-ABL1 transcript levels (International Scale [IS]) at 3 months correlated with complete cytogenetic response (CCyR) by 24 months. Patients with BCR-ABL1 (IS) of > 1% to ≤ 10% at 3 months with nilotinib had higher cumulative incidence of CCyR by 24 months than patients with BCR-ABL1 (IS) of > 10% (53% v 16%). BCR-ABL1 (IS) at 3 months predicted major molecular response (MMR) by 24 months. Cumulative incidence of MMR by 24 months for patients with BCR-ABL1 (IS) of > 0.1% to ≤ 1%, > 1% to ≤ 10%, and > 10% was 65%, 27%, and 9%, respectively. These differences were observed for patients with or without baseline BCR-ABL1 mutations and for those with imatinib resistance or intolerance. Estimated event-free survival (EFS) rates at 24 months decreased with higher transcript levels at 3 months; patients with BCR-ABL1 (IS) of ≤ 1% had an estimated 24-month EFS rate of 82%, compared with 70% for patients with BCR-ABL1 (IS) of > 1% to ≤ 10% and 48% for patients with BCR-ABL1 (IS) of > 10%. CONCLUSION: Patients with BCR-ABL1 (IS) of > 10% at 3 months had a lower cumulative incidence of CCyR and MMR and lower rates of EFS versus patients with BCR-ABL1 (IS) of ≤ 10%. Prospective studies may determine whether close monitoring or alternative therapies are warranted for patients with minimal initial molecular response.


Subject(s)
Antineoplastic Agents/therapeutic use , Benzamides/therapeutic use , Fusion Proteins, bcr-abl/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Adolescent , Adult , Disease-Free Survival , Drug Resistance, Neoplasm , Fusion Proteins, bcr-abl/biosynthesis , Humans , Imatinib Mesylate , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism , Mutation , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Remission Induction , Survival Rate , Treatment Outcome , Young Adult
18.
N Engl J Med ; 362(24): 2251-9, 2010 Jun 17.
Article in English | MEDLINE | ID: mdl-20525993

ABSTRACT

BACKGROUND: Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib. We evaluated the efficacy and safety of nilotinib, as compared with imatinib, in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase. METHODS: In this phase 3, randomized, open-label, multicenter study, we assigned 846 patients with chronic-phase Philadelphia chromosome-positive CML in a 1:1:1 ratio to receive nilotinib (at a dose of either 300 mg or 400 mg twice daily) or imatinib (at a dose of 400 mg once daily). The primary end point was the rate of major molecular response at 12 months. RESULTS: At 12 months, the rates of major molecular response for nilotinib (44% for the 300-mg dose and 43% for the 400-mg dose) were nearly twice that for imatinib (22%) (P<0.001 for both comparisons). The rates of complete cytogenetic response by 12 months were significantly higher for nilotinib (80% for the 300-mg dose and 78% for the 400-mg dose) than for imatinib (65%) (P<0.001 for both comparisons). Patients receiving either the 300-mg dose or the 400-mg dose of nilotinib twice daily had a significant improvement in the time to progression to the accelerated phase or blast crisis, as compared with those receiving imatinib (P=0.01 and P=0.004, respectively). No patient with progression to the accelerated phase or blast crisis had a major molecular response. Gastrointestinal and fluid-retention events were more frequent among patients receiving imatinib, whereas dermatologic events and headache were more frequent in those receiving nilotinib. Discontinuations due to aminotransferase and bilirubin elevations were low in all three study groups. CONCLUSIONS: Nilotinib at a dose of either 300 mg or 400 mg twice daily was superior to imatinib in patients with newly diagnosed chronic-phase Philadelphia chromosome-positive CML. (ClinicalTrials.gov number, NCT00471497.)


Subject(s)
Antineoplastic Agents/therapeutic use , Leukemia, Myeloid, Chronic-Phase/drug therapy , Piperazines/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Benzamides , Blast Crisis/prevention & control , Disease Progression , Female , Fusion Proteins, bcr-abl/antagonists & inhibitors , Humans , Imatinib Mesylate , Kaplan-Meier Estimate , Leukemia, Myeloid, Chronic-Phase/pathology , Male , Middle Aged , Piperazines/adverse effects , Protein Kinase Inhibitors/administration & dosage , Protein Kinase Inhibitors/adverse effects , Pyrimidines/administration & dosage , Pyrimidines/adverse effects , Young Adult
19.
Nucleic Acids Res ; 38(2): 647-59, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19910374

ABSTRACT

In general, splicing regulatory elements are defined as Enhancers or Silencers depending on their positive or negative effect upon exon inclusion. Often, these sequences are usually present separate from each other in exonic/intronic sequences. The Composite Exonic Splicing Regulatory Elements (CERES) represent an extreme physical overlap of enhancer/silencer activity. As a result, when CERES elements are mutated the consequences on the splicing process are difficult to predict. Here, we show that the functional activity of the CERES2 sequence in CFTR exon 12 is regulated by the binding, in very close proximity to each other, of several SR and hnRNP proteins. Moreover, our results show that practically the entire exon 12 sequence context participate in its definition. The consequences of this situation can be observed at the evolutionary level by comparing changes in conservation of different splicing elements in different species. In conclusion, our study highlights how it is increasingly difficult to define many exonic sequences by simply breaking them down in isolated enhancer/silencer or even neutral elements. The real picture is close to one of continuous competition between positive and negative factors where affinity for the target sequences and other dynamic factors decide the inclusion or exclusion of the exon.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Exons , RNA Splicing , Regulatory Sequences, Ribonucleic Acid , Animals , Base Sequence , Binding Sites , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Evolution, Molecular , HeLa Cells , Heterogeneous-Nuclear Ribonucleoproteins/metabolism , Humans , Mice , Molecular Sequence Data , Mutation , Nuclear Proteins/metabolism , RNA-Binding Proteins/metabolism , Serine-Arginine Splicing Factors
20.
J Clin Oncol ; 27(25): 4204-10, 2009 Sep 01.
Article in English | MEDLINE | ID: mdl-19652056

ABSTRACT

PURPOSE: Nilotinib is a second-generation tyrosine kinase inhibitor indicated for the treatment of patients with chronic myeloid leukemia (CML) in chronic phase (CP; CML-CP) and accelerated phase (AP; CML-AP) who are resistant to or intolerant of prior imatinib therapy. In this subanalysis of a phase II study of nilotinib in patients with imatinib-resistant or imatinib-intolerant CML-CP, the occurrence and impact of baseline and newly detectable BCR-ABL mutations were assessed. PATIENTS AND METHODS: Baseline mutation data were assessed in 281 (88%) of 321 patients with CML-CP in the phase II nilotinib registration trial. RESULTS: Among imatinib-resistant patients, the frequency of mutations at baseline was 55%. After 12 months of therapy, major cytogenetic response (MCyR) was achieved in 60%, complete cytogenetic response (CCyR) in 40%, and major molecular response (MMR) in 29% of patients without baseline mutations versus 49% (P = .145), 32% (P = .285), and 22% (P = .366), respectively, of patients with mutations. Responses in patients who harbored mutations with high in vitro sensitivity to nilotinib (50% inhibitory concentration [IC(50)] 150 nM; Y253H, E255V/K, F359V/C) had less favorable responses, as 13%, 43%, and 9% of patients with each of these mutations, respectively, achieved MCyR; none achieved CCyR. CONCLUSION: For most patients with imatinib resistance and with mutations, nilotinib offers a substantial probability of response. However, mutational status at baseline may influence response. Less sensitive mutations that occurred at three residues defined in this study, as well as the T315I mutation, may be associated with less favorable responses to nilotinib.


Subject(s)
Antineoplastic Agents/therapeutic use , Fusion Proteins, bcr-abl/antagonists & inhibitors , Fusion Proteins, bcr-abl/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Mutation , Protein Kinase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Australia , Benzamides , Drug Resistance, Neoplasm/genetics , Europe , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Leukemic , Humans , Imatinib Mesylate , Korea , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/enzymology , Piperazines/therapeutic use , Time Factors , Treatment Outcome , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...